Plain-English translation of NCT07154264 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called in combination with an established treatment called for people who have been newly diagnosed with chronic lymphocytic leukemia or small lymphocytic lymphoma (blood cancers of white blood cells). The study has two parts: first, researchers will carefully test the safety of the medication combination in a small group, and then they will expand to more participants to see how well this treatment works.
Current treatments for these blood cancers help many people, but doctors are always looking for safer and more effective combinations. This trial aims to discover whether this medication can improve outcomes for newly diagnosed patients when used alongside existing therapy.
You likely qualify if…
You likely don't qualify if…
You would take the new medication by mouth once daily for 28 days in each treatment cycle. Starting in the fourth cycle, you would also begin taking (an existing medication) by mouth once daily for 28 days alongside the new treatment. The study includes a careful safety monitoring phase with a smaller group first, followed by expansion to more participants, so the exact schedule and duration may depend on which phase you join and how well you respond to treatment.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
China